Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T20:52:34.663Z.
Calculation as of: 2026-10-06T20:52:34.663Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 869efbf6e11e98c8b36b953a9b631e7639c239a9e2012f11ad9cca4b0e6b7a7d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2024-05-09.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
710.97x
EV/FCF RATIO AVG 3Y
N/A
EV/FCF RATIO AVG 5Y
N/A
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$634.30M
EV/FCF Ratio
15.06x
TTM Avg
38.21x
3Y Avg
38.21x
5Y Avg
21.28x
Market Cap
$656.59M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OmniAb, Inc. (OABI) | $630.63M | N/A | 710.97x | N/A | N/A |
| Prime Medicine, Inc. (PRME)vs › | $632.16M | N/A | N/A | N/A | N/A |
| Zevra Therapeutics, Inc. (ZVRA)vs › | $634.30M | 15.06x | 38.21x | 38.21x | 21.28x |
| Aura Biosciences, Inc. (AURA)vs › | $638.20M | N/A | N/A | N/A | N/A |
| SOPHiA GENETICS S.A. (SOPH)vs › | $619.15M | N/A | N/A | N/A | N/A |
| Climb Bio, Inc. (CLYM)vs › | $611.57M | N/A | 370.81x | 370.81x | 370.81x |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $656.59M | N/A | N/A | N/A | N/A |
| Starling Oncology, Inc. (STLN)vs › | $657.89M | N/A | N/A | N/A | N/A |
| Annexon, Inc. (ANNX)vs › | $660.29M | N/A | N/A | N/A | N/A |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $597.55M | 4.93x | 12.45x | 11.11x | 9.59x |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2024-05-09 | 664.22x |
| 2024-05-08 | 659.94x |
| 2024-05-07 | 667.06x |
| 2024-05-06 | 684.16x |
| 2024-05-03 | 678.46x |
| 2024-05-02 | 668.49x |
| 2024-05-01 | 662.79x |
| 2024-04-30 | 645.69x |
| 2024-04-29 | 659.94x |
| 2024-04-26 | 651.39x |
| 2024-04-25 | 644.27x |
| 2024-04-24 | 662.79x |
| 2024-04-23 | 674.19x |
| 2024-04-22 | 679.89x |
| 2024-04-19 | 678.46x |
| 2024-04-18 | 667.06x |
| 2024-04-17 | 694.14x |
| 2024-04-16 | 699.83x |
| 2024-04-15 | 718.36x |
| 2024-04-12 | 732.60x |
| 2024-04-11 | 753.98x |
| 2024-04-10 | 761.10x |
| 2024-04-09 | 786.75x |
| 2024-04-08 | 769.65x |
| 2024-04-05 | 769.65x |
| 2024-04-04 | 775.35x |
| 2024-04-03 | 779.62x |
| 2024-04-02 | 765.37x |
| 2024-04-01 | 776.77x |
| 2024-03-28 | 785.32x |
| 2024-03-27 | 781.05x |
| 2024-03-26 | 752.55x |
| 2022-03-25 | 779.53x |
| 2022-03-24 | 780.29x |
| 2022-03-23 | 774.16x |
| 2022-03-22 | 774.16x |
| 2022-03-21 | 774.16x |
| 2022-03-18 | 774.16x |
| 2022-03-17 | 776.46x |
| 2022-03-16 | 774.92x |
| 2022-03-15 | 774.16x |
| 2022-03-14 | 774.16x |
| 2022-03-11 | 774.16x |
| 2022-03-10 | 774.54x |
| 2022-03-09 | 774.54x |
| 2022-03-08 | 773.39x |
| 2022-03-07 | 773.39x |
| 2022-03-04 | 773.39x |
| 2022-03-03 | 773.39x |
| 2022-03-02 | 773.39x |
| 2022-03-01 | 774.16x |
| 2022-02-28 | 771.85x |
| 2022-02-25 | 771.85x |
| 2022-02-24 | 771.85x |
| 2022-02-23 | 771.85x |
| 2022-02-22 | 771.85x |
| 2022-02-18 | 771.85x |
| 2022-02-17 | 772.24x |
| 2022-02-16 | 772.24x |
| 2022-02-15 | 772.62x |
| 2022-02-14 | 772.62x |
| 2022-02-11 | 772.62x |
| 2022-02-10 | 772.62x |
| 2022-02-09 | 772.62x |
| 2022-02-08 | 772.62x |
| 2022-02-07 | 772.62x |
| 2022-02-04 | 772.62x |
| 2022-02-03 | 772.62x |
| 2022-02-02 | 772.62x |
| 2022-02-01 | 772.62x |
| 2022-01-31 | 767.25x |
| 2022-01-28 | 765.72x |
| 2022-01-27 | 767.25x |
| 2022-01-26 | 765.72x |
| 2022-01-25 | 765.72x |
| 2022-01-24 | 770.32x |
| 2022-01-21 | 770.32x |
| 2022-01-20 | 773.39x |
| 2022-01-19 | 773.39x |
| 2022-01-18 | 774.92x |
| 2022-01-14 | 774.92x |
| 2022-01-13 | 774.92x |
| 2022-01-12 | 774.92x |
| 2022-01-11 | 774.92x |
| 2022-01-10 | 774.92x |
| 2022-01-07 | 774.92x |
| 2022-01-06 | 771.85x |
| 2022-01-05 | 771.85x |
| 2022-01-04 | 773.39x |
| 2022-01-03 | 773.77x |
| 2021-12-31 | 773.39x |
| 2021-12-30 | 773.39x |
| 2021-12-29 | 770.32x |
| 2021-12-28 | 770.32x |
| 2021-12-27 | 770.32x |
| 2021-12-23 | 770.32x |
| 2021-12-22 | 771.85x |
| 2021-12-21 | 771.85x |
| 2021-12-20 | 771.85x |
| 2021-12-17 | 771.85x |
| 2021-12-16 | 771.85x |
| 2021-12-15 | 771.85x |
| 2021-12-14 | 772.62x |
| 2021-12-13 | 773.39x |
| 2021-12-10 | 770.32x |
| 2021-12-09 | 773.39x |
| 2021-12-08 | 770.32x |
| 2021-12-07 | 773.39x |
| 2021-12-06 | 773.39x |
| 2021-12-03 | 773.39x |
| 2021-12-02 | 773.39x |
| 2021-12-01 | 773.39x |
| 2021-11-30 | 773.39x |
| 2021-11-29 | 773.39x |
| 2021-11-26 | 773.39x |
| 2021-11-24 | 773.39x |
| 2021-11-23 | 773.39x |
| 2021-11-22 | 772.62x |
| 2021-11-19 | 771.09x |
| 2021-11-18 | 771.09x |
| 2021-11-17 | 771.09x |
| 2021-11-16 | 771.09x |
| 2021-11-15 | 771.09x |
| 2021-11-12 | 771.09x |
| 2021-11-11 | 771.09x |
